Iomab-B
Actinium Pharmaceuticals
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'sierra ']
#eha2023 | sierra trial results with a targeted radiotherapy, iomab-b, a myeloablative conditioning with reduced intensity tolerability yields high cr, long term survival in hsct ineligible active r/r aml | positive results presented available here: $atnm 
Actinium is developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently investigating therapies in #AML #BMT $ATNM